ArticleMethods in molecular biology (Clifton, N.J.)2019
Sustainability in Biobanking.
Article in Methods in molecular biology (Clifton, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Extending Specimens to Save Plant DNA: Structuring Department DNA Collections in Times of Biodiversity Loss.Ecology and evolution · 2026Article
- From ISO 9001:2015 to ISO 20387:2018: a proposed implementation roadmap for biobanks.Frontiers in genetics · 2026Article
- Estimating the use of biological samples in Finnish biobanks and hospital collections.European journal of human genetics : EJHG · 2025Article
- Biobanks as an Indispensable Tool in the "Era" of Precision Medicine: Key Role in the Management of Complex Diseases, Such as Melanoma.Journal of personalized medicine · 2024Review
- Digital Biobanking and Big Data as a New Research Tool: A Position Paper.Healthcare (Basel, Switzerland) · 2023Article
- Challenges and Opportunities for Global Genomic Surveillance Strategies in the COVID-19 Era.Viruses · 2022Review
- Sustainable biobanks: a case study for a green global bioethics.Global bioethics = Problemi di bioetica · 2022Article
- Promise and challenges of dystonia brain banking: establishing a human tissue repository for studies of X-Linked Dystonia-Parkinsonism.Journal of neural transmission (Vienna, Austria : 1996) · 2021Article
- The Future of Biobanking: What Is Next?Biotech (Basel (Switzerland)) · 2020Article
- Article
- Assessing and measuring financial sustainability model of the Spanish HIV HGM BioBank.Journal of translational medicine · 2020Article
- Pathology and Biobanking.Turk patoloji dergisi · 2020Review
- How to Make a Cost Model for the Birth Cohort Biobank in China.Frontiers in public health · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Biobanks are storage places for biospecimens that can be used for current and future scientific research. Biospecimens are exceptional sources of biological data that can be potentially translated from molecular and genetic information to clinically relevant treatment modalities. Examples of such biospecimens include, but are not limited to, blood, skin, hair, saliva, stem cells, DNA, and RNA. The volume of biospecimens worldwide continues to grow at an extraordinary rate posing a challenge for biobanks to manage this growth. Due to the vital role of biobanks in research, an understanding of biobanking sustainability is important. Simply starting to collect biospecimens without strategic planning and cost analysis can lead to failure. Components vital to sustainability include fostering public support, cost-effective banking, funding development, standardized protocols, and interoperability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.